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Chapter 1- Introduction 
Amyotrophic Lateral Sclerosis  
Neurodegenerative diseases are among the most common diseases affecting aging 
population including 50 million Americans targeted each year (Brown 2005). Neurodegenerative 
diseases are characterized by death of neuronal cells. Neurons are post-mitotic, hence once the 
cells die, there is no replenish of the lost neurons (Friedman 2011). There are many factors 
contributing to the onset of neurodegenerative diseases. However, most common factors in 
neurodegenerative diseases include 1) protein aggregation and 2) oxidative stress, which is 
associated with mitochondria dysfunction (Sheikh 2012).   
 First discovered in 1869 by French neurologist Jean Martin Charcot, amyotrophic lateral 
sclerosis (ALS) is a neurodegenerative disease affecting both upper and lower motor neurons 
leading to paralysis and eventually death due to diaphragm failure (Redler 2012). Upper motor 
neurons extend from the motor cortex in the brain and lower motor neurons extend from the 
spinal cord to innervate skeletal muscles that allows for voluntary movement. Interestingly, ALS 
does not affect cognitive ability, sensation, and autonomic function, such as breathing and 
digestive process. It is currently the most common neurodegenerative disease affecting 1-2 
person per 100,000 people worldwide (Redler 2012). Death usually occurs 2 to 5 years after 
disease onset. In recent studies, the U.S ALS mortality rate is 1.84 per 100,000 persons.  
There are two onset forms of ALS: either spinal or bulbar (Wijesekera 2009). Spinal ALS 
onset is characterized by muscle weakness in upper and lower limbs. It also includes focal 
muscle atrophy of upper and lower limbs along with fasciculations (spontaneous contraction) and 
spasticity (pull). On the other hand, bulbar ALS onset is characterized by difficulty in speech, 
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swallowing and develop excessive drooling. Bulbar onset also express fasciculations and 
spasticity of the tongue. As ALS progresses, patients experience both spinal and bulbar traits 
(Wijesekera 2009). Roughly 82% of ALS cases are sporadic showing no trace of hereditability 
and about 5-10% cases are familial ALS (fALS) and autosomal dominant. Of the fALS cases, 
20% are associated with mutations in superoxide dismutase 1 (SOD1). SOD1 is an enzyme that 
scavenges toxic superoxide radicals to produce hydrogen peroxide (H2O2). To date, over 100 
mutations in SOD1 have been identified as causative for fALS. 
Protein aggregation  
 In neurodegenerative diseases, protein aggregates are found in the brain tissues and these 
misfolded proteins can cause dysfunctions in neurons. It has been discovered that protein 
aggregates in neurodegenerative diseases are usually in beta-sheet structures, which increase 
protein rigidity (Takalo 2013). There are different proteins aggregates found in cases of ALS. 
Aggregates of TAR binding DNA protein 43 (TDP-43), a gene regulator protein, are found in 
neuronal and glial cells and localized to the cytoplasm from the nucleus of spinal cord motor 
neurons in both sporadic and familial cases of ALS (Blokhuis 2013). Another mutated protein 
associated with ALS is fused in sarcoma/translocated in liposarcoma (FUS), a nuclear protein. 
FUS aggregates were initially discovered in fALS cases but then found in 1% of sALS cases. 
These protein aggregates tend to cause dysfunction of the lower motor neurons (Blokhuis 2013). 
Mutation in a protein with unknown function is characterized to be a major cause of fALS and is 
called C9orf72 (chromosome 9 open reading frame 72) (Blitterswijk 2014). Normally, there are 
hexanuceleotide GGGGCC repeats in this protein but it becomes toxic when there are hundreds 
to a thousand repeats present, causing a gain-of-function in RNA (Blitterswijk 2014).   
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 Protein aggregates produce cell death because they can cause cellular important proteins 
to misfold and aggregate to the growing protein aggregation causing those proteins to lose their 
function and consequently cell survival might be affected.  Cells have protective mechanisms 
against protein aggregation called the protein quality control (PQC), which include chaperones 
and ubiquitin-proteasome system (UPS) (Takalo 2013). Chaperone proteins help prevent protein 
misfolding, disaggregate protein complexes, and cooperate with proteases to degrade proteins 
with the aid of ATP hydrolysis (Lindberg 2015). Heat shock proteins are the largest chaperone 
family and are upregulated under conditions of cellular stress including high temperature and 
oxidative stress.  The UPS targets proteins for degradation. Within the UPS, ligases (E1, E2, E3) 
first recognize and tag misfolded proteins with a chain of four to five ubiquitin to lysine residues. 
This tag is then recognized by 26R proteasome complex, a protease which degrades misfolded 
proteins. The UPS is usually accompanied by chaperones to recruit the ligases and so both 
chaperones and UPS work hand- in- hand to clear misfolded proteins. It has been hypothesized 
that deficiencies in PQC system could also initiate protein accumulation and mutations in 
proteins that play a role in aiding PQC (Takalo 2013).    
Oxidative stress   
Cellular oxidative stress is characterized by the formation of superoxide radicals, reactive 
species which produce cellular toxicity through adduct formation, protein misfolding and lipid 
peroxidation (Uttara 2009) which possess an extra unshared electron. Because the brain 
consumes about 20-30% oxygen, making it the tissue utilizing the most oxygen in our body, 
reactive oxygen species (ROS) are more prevalent and produce greater levels of toxicity than in 
other tissues (Sultana 2013).  Under normal conditions 1-2% of the oxygen is converted to ROSs 
(Uttara 2009). In neurons the major producers of ROSs are NADPH oxidase and xanathine 
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oxidase present in the cytosol and monoamine oxidase, complex I and complex III in the 
mitochondria (Gandhi 2012). NADPH oxidase is an enzyme that donates an electron from 
NADPH to oxygen to form superoxide (O2-); xanathine oxidase is an enzyme that transfers 
electron to oxygen in order to form uric acid, superoxide, and hydrogen peroxide (Gandhi 2012). 
Monoamine oxidase converts amine to aldehyde and hydrogen peroxide (Holschneider 2000). 
Complex 1 and complex III are enzymes that play a role in oxidative phosphorylation on the 
inner mitochondria membrane transferring electron from NADH to the final electron acceptor 
oxygen (Gandhi 2012). Complex I releases superoxide to mitochondria matrix and complex III 
releases superoxide to the inner mitochondria membrane (Hroudova 2014). Hence, dysfunction 
of mitochondria can lead to oxidative stress and has been a characteristic in neurodegenerative 
diseases (Gandhi 2012).  
ROS are problematic because they are highly reactive due to their electron deficiency and 
consequently participate in many redox reactions with macromolecules leading to a cascade of 
redox reactions (Sultana 2013). ROS can cause carbonylation of proteins, which, in turn, produce 
reactive ketones and aldehydes that react with other molecules and so on. Furthermore, ROS can 
cause DNA breaks and DNA mutations by reacting with DNA backbone and individual nucleic 
acid bases. ROS react with brain’s high concentration of polyunsaturated fatty acids (PUFA), 
which are fatty acids containing more than one double bond in its structure, in neuronal 
membranes (Sultana 2013). PUFA are important for signal transduction (Bazinet 2014) and ROS 
breaks it down producing malondialdehyde which in turn disrupts proteins required for DNA 
stability. (Gemma 2007). When there are too many ROSs for cells to overcome, cell toxicity 
reaches its maximum and the cell dies (Fulda 2010). 
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SOD1  
Cu/Zn Superoxide dismutase 1 (SOD1) is an antioxidant enzyme that coverts superoxide 
(O2-) to dioxide (O2) and (H2O2), which can then detoxify to water by oxidase (Banci 2008). It is 
conserved throughout many organisms, including humans (Figure 1). SOD1 is a homodimer with 
each SOD1 containing copper and zinc in its structure. Copper plays a catalytic role while zinc 
plays a structural role (Rahkit 2006). The dimer also consists of a disulfide bond which holds the 
two SOD1 units together (Sea 2015) and prevents it from aggregation if metal is deficient 
(Franco 2013). It is noted that the metals promote the disulfide bonds (Redler 2012). When 
SOD1 interacts with superoxide (O2-), it donates an electron from Cu2+ to oxide making 
molecular oxygen (O2) and copper reduces to Cu+, which becomes Cu2+ again when it comes in 
contact with another O2- and 2H to produce hydrogen peroxide (H2O2) (Franco 2013).   
Mutations in SOD1 affect both protein aggregation along with oxidative stress. There are 
roughly over 100 missense mutations in SOD1 that are associated with ALS. Interestingly, the 
function of SOD1 is retained in the presence of a mutation.  Moreover, transgenic mice with 
SOD1 knockout did not develop ALS, leading to the idea that the function of SOD1 is not 
required for onset of the disease (Redler 2012). Many experiments have discovered that there is a 
correlation between increased mutant SOD1 aggregation and decreased survival time (Redler 
2012).  In human SOD1, there is a cysteine on the 111th amino acid sequence but a serine is 
present in Drosophila SOD1 at the corresponding position. In previous study by Cozzolino et al., 
a mouse motorneuron cell line NSC-34 was transfected with human fALS associated mutant 
SOD1. Mutants of human SOD1, C6F and G93A, formed insoluble aggregates in the cells. 
However, in double mutants containing C111S, solubility of aggregates was increased and 
toxicity decreased. Moreover, the presence of SOD1C111S increased solubility of triple mutant 
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SOD1C6F/C57S/C146R and inhibited aggregate formation in SOD1G93A/C111S and SOD1C6F/C111S. 
Furthermore, it was shown the wildtype SOD1 became insoluble in the presence of mutant 
SOD1G93A but with co-transfection of SOD1G93A/C111S, insoluble SOD1wt recovered to it normal, 
soluble state. These results led to the hypothesis that the 111Cysteine residue is essential to 
aggregate formation and toxicity.   To test this idea further, we modified the endogenous 
Drosophila SOD1 gene to create SOD1S111C and assessed general toxicity through lethality 
studies.   
Drosophila melanogaster as a model of ALS 
Drosophila melanogaster proves to be an excellent model organism to study disease 
mechanisms in vivo for many reasons including a quick life cycle (10-14 days), a large number 
of progeny, a small and fully sequenced genome with high conservation with mammals cheap 
and easy maintenance, and most importantly, it contains many genes that have been conserved 
among of mammalian (McGurk 2015). D. melanogaster has homolog of about 75% of human 
genes making D. melanogaster a very valuable model organism to study genetic diseases 
(Jackson 2008). Furthermore, D. melanogaster and human neurons share common cellular 
components, like cell signaling and trafficking, which makes D. melanogaster even more 
valuable to study neurodegenerative diseases (Sheikh 2013). 
One key feature that makes D. melanogaster an important model organism is its ability to 
undergo homologous recombination (Rong 2002). Homologous recombination is the process by 
which D. melanogaster can exchange a part of its genomic DNA with an injected donor plasmid 
DNA. This process leads to the manipulation of D. melanogaster genomic DNA and allows 
researchers to study mutations and even study human genes (Rong 2002).  
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In this thesis, we are testing the idea that human-like SOD1 will promote protein 
aggregation since D. melanogaster-like SOD1 abolished protein aggregation. Additionally, we 
are testing the eclosion ratio of D. melanogaster with SOD1S111C in the presence of another 
mutation SOD1G85R to test the effect, if any, of SOD1S111C.  
8	  
	  
Chapter 2- Materials and Methods  
Materials 
Drosophila Stocks with Bloomington Stock Numbers 
5905 w1118 
6934 y[1] w[*]; P{ry[+t7.2]=70FLP}11 P{v[+t1.8]=70I-SceI}2B sna[Sco]/CyO, S[2] 
2475 w[*]; T(2;3)ap[Xa], ap[Xa]/CyO; TM3, Sb[1] 
851 y[1] w[67c23] P{y[+mDint2]=Crey}1b; D[*]/TM3, Sb[1] 
33821 w[1118]; wg[Sp-1]/CyO; sens[Ly-1]/TM6B, Tb[1] 
5580 y[d2] w[1118] P{ry[+t7.2]=ey-FLP.N}2 
Mutagenesis Primers 
sod S111C 1 CGTCCGATGATGCAGTCGGCACCGAAG   
sod S111C 2 CTTCGGTGCCGACTGCATCATCGGACG   
Sequencing Primers 
A2-S-F1  TTCCAAGGAATGCAACAGC   
A2-S-F2  CTAGCGAAACGGAAGGAG   
A2-S-F3  TTCGTCGAGCAACAAGTG   
A2-S-F4  TACGGATTGAAGTGCGGTC   
A2-S-R1  GATCTGGGCAACATTGAGG   
A2-S-R2  ATCAAGATACTCGCCACATG   
A2-S-R3  TCAGGCTGCTAAACGAAG   
A2-S-R4  GACCAGAATAAAGGGCAGC   
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Methods 
Fly Care 
D. melanogaster were obtained from Bloomington Drosophila Stock Center and kept at 23oC fly 
incubator with a 12h/12h light/dark cycle and raised on standard Gelbart food.  
 
Mutagenesis 
Mutagenesis was performed on pW25.2sodwt vector that contained sodwt and ampR gene 
(Figure 2) using QuikChange II Xl Site-Directed Mutagenesis Kit and then digested with EcoR1 
enzyme. Five products of mutagenesis (1, 3, 6, 12, 13) were digested with Acc65i and Not1 to 
isolate mutated arm-2. Arm-2 from clone 6 was cut-out from low melting agarose gel and ligated 
with pW25.2SOD1wt without arm-2 using standard protocols. After isolating DNA by Qiagen 
Mini Prep Kit purification, samples were sent to University of Rhode Island for Sanger 
sequencing.  
 
Injection and Homologous Recombination 
pW25.2 vector containing SOD1S111C was sent to Genetics Service Inc. for injection into 
the D. melanogaster embryos’ germ line cells.  
Homologous recombination was performed based on protocols adopted from Staber et al 
(2011). After receiving injected flies, the first step was to mate the injected flies with w1118 flies 
and then cross the progeny with red eyes to Drosophila stock line 2475. we crossed the flies with 
flpI-sceI/CYO and heat shocked the embryos for one hour to activate the enzyme flippase that 
will excise the p-element out of the genomic DNA and the flies will then undergo homologous 
recombination with the endogenous sod+ on the third chromosome. The final step was to excise 
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the mini white gene and this was done by crossing the flies with fly stock containing Cre 
recombinase.         
 
Genomic DNA of D. melanogaster 
I isolated heterozygous D. melanogaster [sodS111C/ sod+] DNA before crossing the flies 
with Cre recombinase stock. I used GeneJet Genomic DNA Purification Kit; however, I eluted in 
100 µl elution buffer instead of 200 µl to obtain a greater yield of DNA. After isolating genomic 
DNA, I amplified the sod1 gene from the genomic DNA via PCR using PfuII polymerase 
(Agilent).  Cycling parameters consisted of 55 C annealing (30s), 72 C extension (2 min), 92 C 
denaturing for 40 cycles.   
Following Cre recombination to remove the mini-white gene, genomic DNA was isolated and 
PCR was performed as described above.  Then the samples were sent to University of Rhode 
Island for sequencing with primer A2-S-R1.   
 
Eclosion Rate  
I crossed virgin females that contain pW25.2sodS111C/CYO on the second chromosome with 
males that contained sodG85R/Tm3-Ser on the third chromosome. The cross resulted in four 
different genotype progenies: [pW25.2sodS111C/+; sodG85R/+], [pW25.2sodS111C/+; TM3-Ser/+], 
[CYO/+; sodG85R/+], [CYO/+; TM3-Ser/+]. I scored the number of progeny of each genotype 
(Table 1).  
 I also scored progeny from three additional crosses to test the eclosion rate in the 
presence of sodS111C. All the sod mutants were located on the third chromosome and had 
undergone homologous recombination. 
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 [sodS111C/sodS111C] X [sodH71Y/TM3-Ser-GFP]    
 [sodS111C/sodS111C] X [sodloxp/sodloxp]  
 [sodS111C/sodS111C] X [sodG85R/TM3-Ser-GFP]  
I scored the progeny on CO2 pad and performed a chi-square test (Table 2).  
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Chapter 3- Results 
Sod gene is highly conserved among eukaryotic organisms (Figure 1). If we focus just on 
the 111th amino acid position, we can see that position to be highly conserved in most organisms 
as well. However, in human sod there exists a cysteine in 111th position but a serine in 
Drosophila sod. Previous work by Cozzolino et al. showed that human sodC111S abolished protein 
aggregation in a mouse motor neuron cell line when this mutant protein was expressed in 
combination with ALS-causing sod mutations (such as sodA4V).  To test whether a cysteine is 
associated with toxicity, our experimental approach was to mutate Drosophila sodwt to sodS111C 
and assess phenotypes.. 
Mutagenesis 
In order to model sodS111C in Drosophila we first had to create the mutation in a vector 
that will be injected in Drosophila embryonic cells. We used pW25.2sodwt vector (Figure 2) to 
introduce sodS111C via site-directed mutagenesis at the appropriate location. Our mutation of 
interest is located in arm-2 within the sod gene. The ampR gene, coding for ampicillin resistance, 
allowed us to select transformed bacterial cells containing the plasmid.  The pW25.2 vector 
serves as a construct for homologous recombination in Drosophila.  Embedded between arm-1 
and arm-2 is the presence of the mini-white marker gene and loxp that allowed us to trace our 
mutation in Drosophila by the expression of red-eyes. The FRT sites are where flippase will 
excise the P-element out of the genomic DNA to initiate homologous recombination. 
We performed site-directed mutagenesis to introduce S111C into the Drosophila sod 
gene.  The process of mutagenesis can cause the vector to rearrange and to check for any 
rearrangements in our vector, we digested our mutagenesis product with EcoR1 restriction 
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enzyme. Following mutagenesis, the sod1 gene was cloned into the Drosophila transformation 
vector and diagnostic digests were performed to verify the integrity of the clone. There are five 
total EcoR1 sites within the plasmid clone with predicted sizes of 295 bp, 662 bp, 696 bp, 5350 
Kb, 6570 Kb.  After transformation, 18 ampicillin resistant colonies were selected at random, 
and DNA was isolated from grown colonies.  EcoRI restriction digests were performed to 
determine the integrity of the clones. Among clones tested, 5 different banding patterns were 
observed (Figure 3).  None of the clones tested showed expected DNA fragments and we 
inferred pW25.2SOD1S111C to have rearranged during mutagenesis.   
To determine if the relevant portion of genomic sequence for sod1 was intact, we 
performed Not1 and Acc65i digests because these restriction sites are located on both ends of 
sod arm-2.  After Not1 and Acc65i digest of samples we expected arm-2 to drop out producing 2 
bands on a gel:  10 Kb band and 2.5 Kb band (Figure 4). Sample 6 was the only sample among 
the five that gave us the expected 2 bands. Sample 6 was sequenced to confirm that we had the 
S111C mutation in sod1 gene (Figure 5). We confirmed the presence our mutation because there 
exists thymine peak in the proper location. Since the remaining vector of sample 6 was 
rearranged, we ligated arm-2 of sample 6 to the properly arranged pW25.2SODwt vector without 
arm-2.  Now that we had a vector that contained S111C mutation, we wanted to amplify the 
amount of the properly mutated vector by transforming it into competent E. coli cells, isolate and 
sequence the DNA, and finally inject it into Drosophila embryonic cells.    
Genomic DNA 
In order to introduce sodS111C in Drosophila, the injected sod1S111C had to replace a copy 
of the endogenous dsod1wt on the third chromosome and this was accomplished through 
homologous recombination (Figure 6). Briefly, the sodS111C construct was injected into the 
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Drosophila embryonic cells and introduced stably into the Drosophila genome by P-element 
transposition. Stable insertion of the construct was determined by a dominant selectable red eye 
marker.  To determine heritability of the construct, we crossed the injected flies with w1118 stock 
and scored for progeny with red-eyes.  Once verified, the stable insertions were balanced to 
prevent recombination and loss of the transposable element.  Flies containing the stable insertion 
were crossed to Drosophila stock line (2475) which contain balancer chromosomes (CyO for the 
2nd chromosome and TM3Sb for the 3rd chromosome). To determine the location of the P-
element, flies that now expressed CyO and TM3Sb were crossed with Drosophila stock line 
(2475) for a second time. Progenies that expressed red-eyes also expressed TM3Sb, but not CyO 
showed that the location of our P-element was on the second chromosome.  To excise the P-
element from the second chromosome so it can undergo homologous recombination with dsodwt 
on the third chromosome, the flies were crossed with flpI-sceI/CYO and the eggs were heat 
shocked for one hour. Heat shock activates the flippase enzyme and excise the P-element out of 
the second chromosome at FRT sites and then undergo homologous recombination with the 
wildtype sod gene, thus replacing endogenous sodwt with sodS111C.  The product of homologous 
recombination was determined by an eye color change and we screened 5 lines and identified 5 
independent lines.  In order to remove any disruptions in the sodS111C gene that might affect 
expression, we removed the mini-white gene from the sodS111C intron. This was accomplished by 
crossing the flies with Drosophila stock (line 851), expressing the Cre recombinase enzyme.  
leaving behind sodS111C with only loxp embedded in the gene.  Hence, the final product is 
Drosophila in which sodS111C was knocked into the genome within the endogenous sod gene on 
the third chromosome. 
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Mid-way through the process of homologous recombination, we wanted to confirm that 
the flies still contained our P-element in their genome. We isolated genomic DNA and amplified 
only a portion of the sod gene that contained our S111C mutation (500 bp). The electrophoresis 
of the amplified genomic heterozygous showed one clean band at 500 bp, as expected (Figure 7). 
Sequencing of the heterozygous genomic DNA confirmed that the flies did have the mutated 
sodS111C in their genome. The sequencing results (Figure 8) showed a large thymine band and a 
small adenine band right underneath it. Since the genomic DNA was derived from heterozygous 
flies, it contained one copy of the wild-type endogenous sod and one copy of the mutated 
sodS111C, hence the reason why a thymine and an adenine bands are both present. Additionally, to 
determine the presence of sodS111C in homozygous flies we isolated genomic DNA, amplified the 
portion of the gene that contained our mutation and sequencing results showed us one clean 
adenine peak at the expected location (Figure 9). 
Analyzing Progeny Eclosion Rate in the Presence of sodS111C 
To determine if the presence of sodS111C on the second chromosome will have any effects 
in flies heterozygous for sodG85R, a mutation which causes ALS in humans and produces adult 
lethal phenotypes in flies, we crossed virgin females [pW25.2sodS111C/CYO; +/+] with [+/+; 
sodG85R/Tm3-Ser] males and that resulted in four different progeny genotypes, including a 
double mutant [pW25,2sodS111C/+; sodG85R/+] (Figure 10).  After scoring progeny eclosion rate, 
we found that the eclosion percent of expected for all four progeny classes were 100% (Table 1). 
Hence, all progeny types eclosed in Mendelian ratios. To take one step further, we also analyzed 
the effects of sodS111C in the presence of other ALS-associated sod mutants on the third 
chromosome to test if sodS111C will rescue flies containing other sod mutations. We crossed 
homozygous sodS111C flies with heterozygous sodH71Y and also crossed homozygous sodS111C 
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with heterozygous sodG85R. Additionally, we also crossed homozygous sodS111C with 
homozygous sodloxp as a control. The eclosion percent of expected for sodS111C/sodH71Y and 
sodS111C/loxp were 100%, whereas the eclosion percent of expected of sodS111C/sodG85R was 
150%, with a p-value < .001 (Table 2). 
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Chapter 5-Conclusions 
This works describes the creation and partial phenotypic analysis of a point mutation 
within the endogenous Drosophila sod gene.  The sodS111C allele was generated through a process 
of mutagenesis and homologous recombination in vivo. SodS111C stocks were created to analyze 
the mutation’s influence on protein aggregation, if any. We were able to test the effects of this 
mutant by assessing the function of the protein using genetic assays. To examine the effect of 
sodS111C on the second chromosome in the presence of sodG85R on the third chromosome 
appropriate genetic crosses were performed and it was determined that there was no significant 
difference among the eclosion rates of progenies. All four genotypes of progenies eclosed in 
Mendelian ratios. This could be explained by the fact that though one class of progeny genotype 
contained a double mutant sod, there was still the presence of the endogenous sodwt that could 
have masked for the double mutant. 
We also assessed the eclosion rate of flies containing sodS111C in the presence of ALS-
associated sod mutations to determine if S111C mutation rescue those sod mutations. There was 
no effect in eclosion rate with the presence of sodS111C with sodH71Y and sodS111C with sodloxp. 
However, there was a significant increase in the eclosion rate of sodS111C/sodG85R. This showed 
that sodS111C rescued sodG85R because the presence of sodS111C and sodG85R lead to more fly 
eclosions. Hence, it is safe to say that there was no effect on protein aggregation with one copy 
of sodG85R and we can further conclude that sodS111C/sodG85R acts in a similar manner as 
sodwt/sodG85R in Drosophila. In the presence of sodS111C, flies containing sodG85R seem to eclosed 
in higher numbers than progenies that did not contain the sodG85R mutation. If sodS111C did not 
function in a similar manner to the wildtype sod gene, then the eclosion rate of sodS111C/sodG85R 
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would be lower than sodS111C/TM3Ser.  The fact that our results were the opposite, showed that 
the presence of sodS111C could have masked sodG85R, like the endogenous dsodwt in [sodS111C/+; 
sodG85R/dsodwt]. Thus, we can conclude that sodS111C behaves in a similar manner as the 
endogenous dsodwt.  
In future studies, longevity experiments will be performed to assess the ability of S111C 
to rescue pathogenic mutations over time as flies age.   
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Figures 
 
 
 
Figure 1. Clustal W alignment for SOD1 in selected model organisms. SOD1 protein shows a 
high degree of evolutionary conservation. Highlighted areas represent areas of conservations and 
arrow represents the site of S111C mutation. 
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Figure 2. Cartoon depiction of pW25.2SOD1wt vector with ampicillin resistance gene. The 
vector was obtained from Reenan lab at Brown University (Staber et al 2011). Arm-1 and arm-2 
make up SOD1wt gene which is disrupted by mini white marker gene and loxp that allows us to 
follow our vector in D. melanogaster. The FRT sites are where flippase is going to cut and 
excise the vector out of D. melanogaster genome. 
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Figure 3. EcoR1 digest of mutagenesis products of pW25.2SOD1wt. After mutagenesis, 2	  µl 
of products were digested with EcoR1 at 37oC for 2 hours and then ran on 1% agarose gel with 2 
log ladder. Expected 3 band patterns but the gel showed five distinct patterns (a-e).  
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Figure 4. Not1 and Acc65i digest of mutagenesis samples 1, 3, 6,12,13 (see Figure 3). Not1 
and Acc65i isolate arm-2 from pW25.2 vector. Sample were digested for 2 hours at 37oC and 
then ran on 1% agarose gel with 2 log ladder. Expected bands are arm-2 (2.5 Kb) and the 
remaining vector (10 Kb). Lane 6 is the only sample that showed the expected bands.   
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Figure 5.  Sanger sequencing results of pW25.2SOD1S111C after the process of site-directed 
mutagenesis. Vector was sent to University of Rhode Island. In wild-type SOD1wt (top), there 
exist a thymine but after mutagenesis that thymine is mutated to an adenine (bottom). 
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Figure 6. Process of homologous recombination in D. melanogaster with injected 
pW25.2SOD1S111C. After injection, only the p-element incorporates into the genomic DNA. 
Flippase excises the vector at FRT sites and then undergoes homologous recombination with D. 
melanogaster’s third chromosome that contains the endogenous SOD1wt. Cre recombinase 
removes the mini white gene between arm-1 and arm-2. In the end we have one copy on the 
endogenous SOD1wt and one copy of SOD1S111C on the third chromosome.     
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 Figure 7. PCR amplification of sod from genomic DNA. Genomic DNA of heterozygous sod+ 
/sodS111C flies were isolated and amplified with primer set [F3A, R1A] on 1% agarose gel with 2 
log ladder. The expected band is 500 bp. 
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Figure 8. Sanger sequencing result of genomic D. melanogaster DNA. Heterozygous 
sod+/sodS111C flies’ genomic DNA was isolated after homologous recombination and amplified 
with primer A2-S-R1. Sample was sent to University of Rhode Island for sequencing. Arrow 
shows thymine (T) from endogenous sod+ and adenine(A) from mutated sodS111C. 
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Figure 9. Sanger sequencing result of genomic D. melanogaster DNA. Homozygous 
sodS111C/sodS111C flies’ genomic DNA was isolated after homologous recombination and 
amplified with primer A2-S-R1. Sample was sent to University of Rhode Island for sequencing. 
(A) Top alignment shows the sequence of wildtype sod and the bottom alignment shows S111C 
mutated sod sequence, with the red A denoting the mutation from thymine to adenine. 
(B) Genomic DNA sequence of sodS11C peaks. Arrow shows the clean adenine peak, instead of 
thymine, at the site of mutation. 
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Figure 10. Crossing scheme of eclosion rate experiment. The diagram depicts only second and 
third chromosome of D. melanogaster, where the pW25.2sodS111C vector and sodG85R are located 
along with marker genes. The cross results in four different progeny types.  
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Table 1. Eclosion data of progeny from a cross involving heterozygotes of sodS111C and 
sodG85R.  Adult flies of genotypes pW25.2sodS111C/Cyo; +/+ and +/+; sodG85R/TM3-Ser were 
crossed and eclosion numbers of the resulting F1 progeny were scored every other day.   
Expected percentages were based on predicted Mendelian ratios.   
 
 
  
Genotype Eclosion % of Expected Sample size (n) 
pW25.2sodS111C/+; 
sodG85R/+ 
100% 182 
pW25.2sodS111C/+; 
TM3-Ser/+ 
100% 160 
CYO/+; sodG85R/+ 100% 144 
CYO/+; TM3-Ser/+ 100% 181 
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Genotype Eclosion % of Expected Sample Size (n) 
S111C/H71Y 100% 688 
S111C/loxp 100% 505 
S111C/G85R 150% * 81 
Table 2. Eclosion data of progeny from three crosses consisting of sodS111C. Progeny were 
scored on CO2 pad every or every other day. Eclosion percent of expected was calculated as 
(observed/sample size divided by expected) *P-value< .0001 
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